Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miranda C Lahman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Immunology|February 13, 2019
Immunotherapy for skin cancerKelly G Paulson, Miranda C Lahman, Aude G Chapuis, et al.
The Journal of Investigative Dermatology|April 17, 2021
Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell CarcinomaMiranda C Lahman, Kelly G Paulson, Paul T Nghiem, et al.
Mabs|July 22, 2025
AlphaBind, a domain-specific model to predict and optimize antibody-antigen binding affinityAditya A Agarwal, James Harrang, David Noble, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and PersistenceFrancesco Mazziotta, Lauren E Martin, Daniel N Eagan, et al.
Nature Communications|June 5, 2025
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistenceFrancesco Mazziotta, Lauren E Martin, Daniel N Egan, et al.
Science Translational Medicine|February 9, 2022
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependencyMiranda C Lahman, Thomas M Schmitt, Kelly G Paulson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Immunology|February 13, 2019
Immunotherapy for skin cancerKelly G Paulson, Miranda C Lahman, Aude G Chapuis, et al.
The Journal of Investigative Dermatology|April 17, 2021
Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell CarcinomaMiranda C Lahman, Kelly G Paulson, Paul T Nghiem, et al.
Mabs|July 22, 2025
AlphaBind, a domain-specific model to predict and optimize antibody-antigen binding affinityAditya A Agarwal, James Harrang, David Noble, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and PersistenceFrancesco Mazziotta, Lauren E Martin, Daniel N Eagan, et al.
Nature Communications|June 5, 2025
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistenceFrancesco Mazziotta, Lauren E Martin, Daniel N Egan, et al.
Science Translational Medicine|February 9, 2022
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependencyMiranda C Lahman, Thomas M Schmitt, Kelly G Paulson, et al.
Pageof 1